January 4, 2026

@michaelokun

What is the road roadmap for optogenetics to reach human level treatments? Can we go from light to insight? Optogenetics refers to using light to precisely turn specific brain cells on or off in order to understand how circuits work and how to fix them. Lüscher, Deisseroth and colleagues describe in a new Perspective in Nature Neuroscience how optogenetics is shaping discoveries today, and laying out more realistic paths toward future human therapies. Key Points: - Optogenetics has already transformed how we map brain circuits and identify which cells actually cause symptoms. - Many near term benefits will come indirectly by using optogenetic insights to improve medications and neuromodulation like DBS, rather than actually putting light into the human brain. - Direct optogenetic therapies in humans are possible for select conditions, however they demand careful attention to safety ethics and regulation. My take: This paper is really important and a great read. Optogenetics is not just a flashy lab tool. It is a blueprint for smarter therapies. We will need to understand and to respect biology, ethics and timelines for translation. The biggest wins may come from what optogenetics teaches us, rather than from 'where we shine the light.' Here are 5 points that resonated w/ me: 1- Causal circuit knowledge is the real breakthrough, not the light itself. 2- Indirect translation may help folks sooner by refining existing therapies and using 'optogenetic logic.' 3- Direct human applications are feasible for carefully chosen indications like vision and also for focal symptoms. 4- Ethics and 'cognitive liberty' must stay front and center as we move from animals to humans. 5- The future likely blends optogenetics w/ gene therapy, imaging biomarkers and adaptive stimulation. This will allow us to deliver more precise treatment. https://www.nature.com/articles/s41593-025-02097-9 #fixelinstitute #michaelokun #parkinson #optogenetics